The MoneyWeek model portfolio: the top-six investment trusts to put in your Isa
MoneyWeek’s favourite investment trusts are top-notch long-term choices for your portfolio
Since 2012 we have been suggesting a small group of investment trusts for those of you who want to hold a diversified portfolio of funds run by active managers. I promised when we first wrote about it that I would update you on it occasionally (with the help of a panel made up of investment trust experts Sandy Cross, Alan Brierley and Simon Elliott) and change it even more occasionally.
I have mostly stuck to my guns on that. There are six trusts in the portfolio at present: Scottish Mortgage Investment Trust (LSE: SMT), Mid Wynd International Investment Trust (LSE: MWY), Caledonia Investments (LSE: CLDN), Personal Assets Trust (LSE: PNL), RIT Capital Partners(LSE: RCP) and Law Debenture Corporation (LSE: LWDB). So how are they doing? As a group, pretty well.
Over the last year (to 1 March) the six have risen by an average of 29.5%. The standout (as usual) has been Scottish Mortgage. It has returned a whopping 103% in the last 12 months. Myd Wynd, our new addition, is up by 25%, Law Debenture 32.4%, Personal Assets 8.5% and RIT Capital 12.5%. The only negative performance came from Caledonia, which has slipped by 4%. Who’d have thought there was a global pandemic underway?
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The last change we made in the portfolio was in 2020 (1 May). We dumped value-orientated Temple Bar when its longstanding manager left and we had no idea what might happen next. Mid Wynd has gained 24% since. However, so far the switch has been pointless: Temple Bar is also up by 24% since 1 May. Overall, since the switch the portfolio is up by just over 40% (against a 30% rise in the FTSE All World index) and would have been even without the agonising about its construction. This is why I hate making changes to the portfolio.
In November we also wondered whether we should let Law Debenture, our worst performer at the time, go. We decided not to. We like the managers, we like the UK focus and we like the value tilt of the portfolio. This is a bet that has paid off. Phew. Scottish Mortgage and Mid Wynd both stay too. They are performing well and offer a good growth element to the portfolio (in different ways; their top stocks are very different). There has been quite a lot of volatility in Scottish Mortgage’s share price and an increasing number of voices are prepared to dismiss it on the basis that it is little more than a quasi-tech play for gamblers. However for most of the panel the trust is, as Simon puts it “a compelling investment for those prepared to take a long-term view”. You might worry about the valuations of some of its holdings but the managers have a stunning record of stockpicking and performance. Personal Assets is also staying. It just keeps doing what it promises to (protecting the real value of capital) and that works for us.
A safe harbour
So what are we worried about this time? RIT has been causing some mutterings. It has performed well for us recently but only after a fairly drab run. The concern, says Max King, who writes about investment trusts for MoneyWeek and has been invited to chuck opinions into the mix, is that without Lord Rothschild’s “magic touch” (he stepped down as chairman in 2019), RIT might eventually turn into a high-cost, multi-asset fund with nothing to distinguish it from all too many others.
Alan begs to differ. Look back at how RIT has performed since its inception in 1988, he says. The trust has participated in 73% of market upside but only 38% of market declines. That translates into “meaningful outperformance... achieved with lower volatility.” Its “six-cylinder approach” (which involves everything from active currency management to private equity and outsourcing to “exceptional equity managers”) works.
It is a “safe harbour” at a point in the cycle when there is very likely to be some brutal market action ahead. I think it stays – particularly given that it is currently trading on what seems to us to be an entirely undeserved 9% discount to its net asset value (NAV).Caledonia is also causing me mild concern. Alan prefers Pantheon for private-equity exposure; it’s in his own Investec Flexible Model Portfolio. The portfolio, he says, is high-quality with a focus on “defensive sectors such as education, healthcare and technology, which offer growth through innovation or favourable demographic trends [and] are not dependent on GDP growth.”
It is an excellent suggestion. But I’m going to ignore it (for now). Caledonia has definitely been a drag on our performance, but I’d be almost more nervous if all the portfolio constituents rose as one (that’s not how diversification is supposed to work). And Caledonia does at least offer some value: it trades on a discount to NAV of around 20%. I’d also note that the quoted-equity portfolio (36% of the total) has been doing perfectly well (up by 28.5% on a total-return basis in the nine months to the end of December), as has the fund portfolio (26% of the total). The problem then, such as it is, is the private-equity portfolio, which contains a good few lockdown-affected consumer- focused businesses (3% of Caledonia’s total portfolio is in pub chain Liberation Group and another 1% in Buzz Bingo, for example) and which produced returns of a mere 0.5% from March to December.
The private investments are revalued for NAV purposes twice a year, with the next one due in March when, as Sandy points out, there is obvious potential for uplift to valuations and hence to the trust’s NAV. A bias to taking no action has generally served our portfolio pretty well. I think we will stick with it (again).
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
Merryn Somerset Webb started her career in Tokyo at public broadcaster NHK before becoming a Japanese equity broker at what was then Warburgs. She went on to work at SBC and UBS without moving from her desk in Kamiyacho (it was the age of mergers).
After five years in Japan she returned to work in the UK at Paribas. This soon became BNP Paribas. Again, no desk move was required. On leaving the City, Merryn helped The Week magazine with its City pages before becoming the launch editor of MoneyWeek in 2000 and taking on columns first in the Sunday Times and then in 2009 in the Financial Times
Twenty years on, MoneyWeek is the best-selling financial magazine in the UK. Merryn was its Editor in Chief until 2022. She is now a senior columnist at Bloomberg and host of the Merryn Talks Money podcast - but still writes for Moneyweek monthly.
Merryn is also is a non executive director of two investment trusts – BlackRock Throgmorton, and the Murray Income Investment Trust.
-
Investors pulled £4.2bn from equity funds ahead of Budget tax raid
October was the third-worst month on record for fund flows, new figures show, as investors sold assets ahead of the Autumn Budget
By Katie Williams Published
-
What Keir Starmer's ‘Plan for Change’ means for you - six milestones explained
Prime Minister Keir Starmer has set out six milestones that the public can judge the government by - we reveal Labour's top policy targets
By Marc Shoffman Published
-
Warren Buffet invests in Domino’s – should you buy?
What makes Domino's a compelling investment for Warren Buffet's Berkshire Hathaway, and should you buy the UK-listed takeaway pizza chain?
By Dr Matthew Partridge Published
-
Should you buy JPMorgan's top emerging market trust?
The JPMorgan Emerging Markets Trust fund has outperformed its benchmark over the long term and offers good value
By Max King Published
-
4Imprint makes a strong impression – should you buy?
4Imprint, a specialist in marketing promotional products, is the leader in a fragmented field
By Dr Mike Tubbs Published
-
Invest in Glencore: a cheap play on global growth
Glencore looks historically cheap, yet the group’s prospects remain encouraging
By Rupert Hargreaves Published
-
Should you invest in Trainline?
Ticket seller Trainline offers a useful service – and good prospects for investors
By Dr Matthew Partridge Published
-
Two investment trusts riding the AI boom
Remain invested in investment trusts despite high valuations, as computing breakthroughs are likely to change the world
By Max King Published
-
Key takeaways from the MoneyWeek Summit 2024: Investing in a dangerous world
If you couldn’t get a ticket to MoneyWeek’s summit, here’s an overview of what you missed
By MoneyWeek Published
-
DCC: a top-notch company going cheap
DCC has a stellar long-term record and promising prospects. It has been unfairly marked down
By Jamie Ward Published